- Home
- NEWS
- REGIONAL
- THIS WEEK'S PAPER
- BLOGS
- Multimedia
- OPINION
- A&E
- LISTS
- PEOPLE
- EVENTS
- Classifieds
- Subscribe
Life Science & Biotech
Roche Diagnostics to get indirect boon from new test
August 22, 2011
J.K. WallNew drug for metastatic melanoma packaged with genetic test should help Roche sell more of its cobas 4800 laboratory testing
systems.
MoreInventor on quest to bring medical device to market
August 13, 2011
Chris O'MalleyLicensed practical nurse Nic Davis invented a device to kill and prevent the introduction of microorganisms that collect at
catheter ports.
MoreGlick support boosts IU eye research
August 13, 2011
IBJ StaffA $10 million research endowment at the Eugene and Marilyn Glick Eye Institute has attracted seven new researchers to the
Indiana University School of Medicine’s Ophthalmology Department.
MoreHealth care VC slows in 2011
August 8, 2011
J.K. WallFour Hoosier companies attracted more than $10.5 million, down from 10 companies that attracted $18.5 million during the first
half of 2010.
MoreZimmer playing hardball with plaintiffs' lawyers
August 8, 2011
Bloomberg NewsThe Warsaw-based company has sued seven law firms this year and sent warning letters to at least three more, saying their
ads and Internet postings distorted the safety record of its $1.8 billion-a-year knee business.
MoreMedical implant maker plans move from northern Indiana
August 4, 2011
Associated PressRochester Medical Implants plans to move operations from Rochester to Noblesville in October. The company has 28 employees.
MorePackaging manufacturer plans to expand, add 80 jobs
August 2, 2011
Indianapolis-based DGP Intelsius LLC, a manufacturer and distributor of temperature-controlled packaging, announced on Tuesday
morning that it plans to add 80 jobs by 2014 as part of an $870,000 expansion.
MoreMore life sciences firms opt to launch products in Europe
July 30, 2011
Maria LaMagnaThe U.S. Food and Drug Administration's growing reputation for unpredictability is spurring some Indianapolis companies to
join counterparts elsewhere and introduce products in Europe. The upshot is that some Americans may never benefit from innovations
occurring in their backyards.
MoreIndiana life sciences leaders look toward the future
July 30, 2011
Chris O'MalleyFormer Eli Lilly and Co. vice president Richard Dimarchi, BioCrossroads President David Johnson, angel investor Oscar Moralez
and Purdue University Senior Vice President Alan Rebar discuss issues ranging from the depth of the life sciences industry
in Indiana to venture capital and Purdue's Discovery Park.
MoreEli Lilly's Elanco unit blossoming at just the right time
July 30, 2011
Greg AndrewsAn investment firm projects that the Elanco animal-health business will generate sales of nearly $2 billion by 2012 and surpass
$3 billion by 2018.
MoreAngel investment firm adds 3rd chapter for life sciences
July 27, 2011
Chris O'Malley
StepStone Business Partners has added a chapter in biotech hotbed Warsaw as part of what it hopes will eventually
become a statewide network.
Dow AgroSciences reports record sales, higher earnings
July 27, 2011
Second-quarter revenue for the Indianapolis-based company increased 18 percent, to $1.5 billion. The company attributed the
gain to higher prices and stronger demand for its products.
MoreTech district could boost Indianapolis' convention business
July 23, 2011
Scott OlsonThe Indianapolis Convention & Visitors Association plans to attract more life sciences conferences.
MorePfizer won’t break up animal unit for potential Lilly bid
July 21, 2011
Bloomberg NewsPfizer Inc., the world’s biggest drugmaker, said it isn’t interested in breaking up its animal health unit after
Indianapolis-based Eli Lilly and Co. expressed interest in buying some of its products.
MoreLilly loses bid to end revived Zyprexa U.K. patent case
July 5, 2011
Bloomberg NewsThe High Court in London on Tuesday denied Lilly’s request for a judgment without trial against Neopharma Ltd., the
closely held company that has European marketing rights for the generic version of the drug known chemically as olanzapine.
MoreTiming good for 2-in-1 biotech drugs
July 5, 2011
J.K. WallEli Lilly and Co.’s foray into combination drugs is well-timed because the company could take advantage of some the
world’s most successful biotech medicines, which are about to see their patents expire.
MoreLilly plans more investment in two-in-one drugs
June 28, 2011
J.K. WallIndianapolis-based drugmaker Eli Lilly on Tuesday will announce a multimillion-dollar investment to develop drugs that act
like two medicines in one. Lilly plans to add more scientists to back the effort.
MoreLilly CEO: Immigration, tax laws slow innovation
June 23, 2011
Bloomberg NewsThe U.S. government needs to open its borders to attract and retain talented scientists for drugmakers to employ, Eli Lilly
& Co. CEO John Lechleiter plans to tell a technology conference Thursday.
More2010 was great for Indiana's 100 largest companies
June 18, 2011
Norm HeikensDespite enjoying rising revenues and profits, companies haven't followed with big increases in job numbers.
MoreCity leaders look to 16th Street as future tech hub
June 16, 2011
Francesca JaroszOfficials on Thursday shared details of a long-term plan to redevelop an industrial stretch northwest of downtown with the
goal of attracting hundreds of residents and dozens of high-tech companies to the area.
MoreQ&A
June 13, 2011
J.K. WallVi Shukla is a scientific leader at Indianapolis-based Dow AgroSciences LLC, focused on its Exzact Precision
Technology tools for genetic engineering of plants and crops. Dow Agro used the technology in its own crop seed products,
and has also been licensing for use in tomatos and trees.
MoreAnson Group CEO thrives on helping clients work with FDA
June 11, 2011
Ann FinchColleen Hittle became CEO and sole owner of the Indianapolis-based pharmaceutical and medical device consulting firm in April.
MoreCity to roll out plan for 16th Street tech corridor
June 10, 2011
Francesca JaroszThe city of Indianapolis plans to announce a major initiative to turn a stretch of 16th Street northwest of downtown into
a hub for biotechnology and other high-tech companies.
MoreRoche wins as high court limits university patent rights
June 6, 2011
Bloomberg NewsMonday's Supreme Court decision is a victory for companies that collaborate with universities in research. Indianapolis-based
Eli Lilly and Co. was among the companies that supported Roche.
MoreLife sciences logistics firm opens new tissue storage facility
May 27, 2011
J.K. WallBioStorage Technologies' $4.6 million facility, located near the Indianapolis International Airport, will be used to prepare,
store and transport tissue and blood samples.
More
Sponsored by
ADVERTISEMENT
on Facebook & Twitter
on Facebook & Twitter
 Follow IBJ's Tweets on these topics: |
||
| @IBJNews | @Propertylines | @IBJTheScore |
| @IBJArts | @IBJHealthcare | @IBJDining |
| @IBJLists | @IBJSmallbiz | |
ADVERTISEMENT
Back to TopCopyright © All Rights Reserved. Privacy Policy | Terms of Use.
Design, CMS, Hosting & Web Development :: ePublishing.
Additional Hosting & Delivery by
See, I told u Indyman and Dipsicle....this 8 days is overkill. It's barely worth a weekend....great job Tony George! Your dream has been fulfilled....he fans want the I r l back. Thats how good it was.....and that sucked.
I have been in training for a short time now but right off I can see that safety and quality are the number one issues, my experience as of late has been a positive one, the employees along with Jeff the plant manager and the operation supervisor as well as the engineers are a highly motivated group of people, what an asset for the area to have and for company's in need of a quality metal products.
Pimlico
While I understand the severity of their actions as well as everyones eagerness to hold them responsible for thier lost funds, these gentlemen did know how to make money. Dispite thier poor decisions over the ownership of Fair they had made several wise investments which paid them greatly. This proves they do have the potential to rebuild so they can repay. I do not feel they should live the life of luxuary but given an opportunity could they find ways of repaying the debts? They are doing nothing now but being a burden on tax payers. Just a thought!!!!!
You guys have some "interesting" comments to say the least. I hope you will call in and share those opinions starting June 1. I'm looking forward to having you on the air.